EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management

Yihan Zhang, Xing Li, Shang Li, Yu Zhou, Tiantai Zhang, Lan Sun iD

International Journal of Molecular Sciences · 01.08.2024 · 25 (15) · 8427

DOI: 10.3390/ijms25158427 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.08.2024. Verfasst von Yihan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and …. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Immunotherapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation, the CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) is a progressive cardiovascular disease, which may lead to severe cardiopulmonary dysfunction. As one of the main PH disease groups, pulmonary artery hypertension (PAH) is characterized by pulmonary vascular remodeling and right ventricular dysfunction. Increased pulmonary artery resistance consequently causes right heart failure, which is the major reason for morbidity and mortality in this disease. Although various treatment strategies have been available, the poor clinical prognosis of patients with PAH reminds us that further studies of the pathological mechanism of PAH are still needed. Inflammation has been elucidated as relevant to the initiation and progression of PAH, and plays a crucial and functional role in vascular remodeling. Many immune cells and cytokines have been demonstrated to be involved in the pulmonary vascular lesions in PAH patients, with the activation of downstream signaling pathways related to inflammation. Consistently, this influence has been found to correlate with the progression and clinical outcome of PAH, indicating that immunity and inflammation may have significant potential in PAH therapy. Therefore, we reviewed the pathogenesis of inflammation and immunity in PAH development, focusing on the potential targets and clinical application of anti-inflammatory and immunosuppressive therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionImmunotherapyHumansAnimalsInflammationHypertension, PulmonaryVascular Remodeling

Stichwörter der Autor:innen

immunotherapyinflammationpulmonary artery hypertension

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Lan Sun

Förderung

  • the National Natural Science Foundation
  • the CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zhang, Y., Li, X., Li, S., Zhou, Y., Zhang, T., & Sun, L. (2024). Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management. International Journal of Molecular Sciences, 25(15), 8427. https://doi.org/10.3390/ijms25158427

Vancouver

Zhang Y, Li X, Li S, Zhou Y, Zhang T, Sun L. Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management. International Journal of Molecular Sciences. 2024;25(15):8427. doi:10.3390/ijms25158427

BibTeX
@article{Zhang2024,
  author = {Zhang, Yihan and Li, Xing and Li, Shang and Zhou, Yu and Zhang, Tiantai and Sun, Lan},
  title = {Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {15},
  pages = {8427},
  doi = {10.3390/ijms25158427}
}
Kostenlos starten →